Form 6-K ASTRAZENECA PLC For: Oct 26
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/21/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Far-left party wins Berlin election, pledging to nationalise housing
- Cybercrime feud erupts on dark web as notorious group claims hijack of rival's website
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
AstraZeneca (AZN) Confirms FDA Partial Clinical Hold Placed on Patient Recruitment for MEDI4736 Trial in HNSCC; Issues Commentary
October 27, 2016 2:47 PM EDTAstraZeneca (NYSE: AZN) issued the following statement following news that recruitment for its study of MEDI4736 (Durvaluma) in head and neck cancer was halted:
Following the... More
